Guang-Yin Xu Selected Research

pyrrolidine dithiocarbamic acid

1/2020	Downregulation of GRK6 in arcuate nucleus promotes chronic visceral hypersensitivity via NF-κB upregulation in adult rats with neonatal maternal deprivation.
12/2015	Promoted Interaction of Nuclear Factor-κB With Demethylated Purinergic P2X3 Receptor Gene Contributes to Neuropathic Pain in Rats With Diabetes.
7/2015	TLR4 upregulates CBS expression through NF-κB activation in a rat model of irritable bowel syndrome with chronic visceral hypersensitivity.
2/2013	Electroacupuncture suppresses mechanical allodynia and nuclear factor κ B signaling in streptozotocin-induced diabetic rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guang-Yin Xu Research Topics

Disease

29	Hypersensitivity (Allergy) 01/2022 - 08/2009
28	Pain (Aches) 01/2022 - 01/2002
24	Hyperalgesia 12/2021 - 08/2009
18	Inflammation (Inflammations) 04/2022 - 01/2002
13	Visceral Pain 04/2022 - 05/2011
7	Neuralgia (Stump Neuralgia) 12/2021 - 08/2011
6	Chronic Pain 10/2021 - 05/2011
4	Neoplasms (Cancer) 10/2021 - 10/2015
4	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 01/2021 - 08/2009
4	Chronic Pancreatitis 01/2017 - 01/2012
3	Peripheral Nervous System Diseases (PNS Diseases) 10/2021 - 10/2012
3	Intervertebral Disc Displacement (Herniated Disc) 12/2016 - 03/2015
3	AIDS-Related Complex (ARC) 10/2016 - 12/2012
2	Type 2 Diabetes Mellitus (MODY) 12/2021 - 07/2020
2	Diabetes Mellitus 12/2021 - 01/2020
2	Body Weight (Weight, Body) 04/2019 - 10/2015
2	Stroke (Strokes) 11/2018 - 02/2018
2	Bone Neoplasms (Bone Cancer) 12/2017 - 01/2017
2	Diabetic Neuropathies (Diabetic Neuropathy) 02/2013 - 08/2011
1	Neuroinflammatory Diseases 01/2022
1	Tuberculosis (Tuberculoses) 10/2021
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2021
1	Brain Diseases (Brain Disorder) 07/2020
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 02/2020

Drug/Important Bio-Agent (IBA)

16	CystathionineIBA 01/2018 - 08/2009
14	Ligases (Synthetase)IBA 01/2017 - 08/2009
12	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 01/2017 - 08/2009
10	EnzymesIBA 10/2016 - 08/2009
7	Adrenergic Agents (Adrenergic Drugs)IBA 11/2020 - 01/2010
7	Sodium Channels (Sodium Channel)IBA 07/2017 - 01/2013
6	Freund's AdjuvantIBA 01/2021 - 01/2002
6	Proteins (Proteins, Gene)FDA Link 01/2018 - 12/2012
4	Analgesics (Analgesic Drugs)IBA 12/2021 - 02/2013
4	Messenger RNA (mRNA)IBA 10/2021 - 01/2013
4	Norepinephrine (Noradrenaline)FDA LinkGeneric 11/2020 - 01/2010
4	A-317491IBA 11/2020 - 03/2015
4	Purinergic Receptors (Receptors, Purine)IBA 07/2020 - 04/2015
4	pyrrolidine dithiocarbamic acidIBA 01/2020 - 02/2013
4	Streptozocin (Streptozotocin)FDA Link 01/2019 - 02/2013
4	Purinergic P2X3 ReceptorsIBA 01/2017 - 08/2011
3	Adenosine Triphosphate (ATP)IBA 11/2020 - 01/2002
3	Thioctic Acid (Lipoic Acid)IBA 01/2020 - 01/2017
3	Adrenergic Receptors (Adrenergic Receptor)IBA 02/2019 - 01/2010
3	Toll-Like Receptor 4IBA 01/2019 - 07/2015
3	Aminooxyacetic AcidIBA 01/2018 - 01/2013
3	Voltage-Gated Sodium ChannelsIBA 01/2017 - 05/2011
3	Hydroxylamine (Hydroxylamine Hydrochloride)IBA 12/2016 - 01/2013
3	NF-kappa B (NF-kB)IBA 10/2015 - 12/2012
3	sodium bisulfide (NaHS)IBA 02/2013 - 12/2012
2	Protein Kinases (Protein Kinase)IBA 12/2021 - 10/2016
2	Small Interfering RNA (siRNA)IBA 10/2021 - 12/2015
2	Purinergic P2X4 ReceptorsIBA 07/2020 - 11/2018
2	Acid Sensing Ion ChannelsIBA 01/2020 - 01/2020
2	ChemokinesIBA 01/2020 - 01/2016
2	Propranolol (Inderal)FDA LinkGeneric 02/2019 - 01/2014
2	Butoxamine (Butaxamine)IBA 02/2019 - 04/2015
2	Protein Kinase CIBA 07/2017 - 10/2015
2	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 07/2017 - 01/2013
2	CytokinesIBA 01/2017 - 01/2016
2	Sulfonic AcidsIBA 01/2017 - 10/2016
2	salicylhydroxamic acid (SHAM)IBA 01/2017 - 06/2013
2	LyasesIBA 10/2016 - 01/2012
2	chelerythrineIBA 10/2016 - 10/2015
2	SodiumIBA 01/2016 - 02/2013
2	Phosphotransferases (Kinase)IBA 01/2016 - 12/2012
2	Suramin (Suramin Sodium)IBA 12/2015 - 04/2015
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 10/2015 - 12/2012
2	N-Methylaspartate (NMDA)IBA 10/2015 - 12/2012
2	Nerve Growth Factor (NGF)IBA 01/2012 - 01/2010
1	GATA Transcription FactorsIBA 04/2022
1	Carrier Proteins (Binding Protein)IBA 04/2022
1	A-Form DNA (A-DNA)IBA 04/2022
1	Purinergic P2Y ReceptorsIBA 01/2022
1	purinoceptor P2Y6IBA 01/2022
1	G-protein-coupled receptor kinase 6IBA 01/2022
1	N,N''- 1,4- butanediylbis(N'- (3- isothiocyanatophenyl))thioureaIBA 01/2022
1	Blood Glucose (Blood Sugar)IBA 12/2021
1	Pharmaceutical PreparationsIBA 12/2021
1	Adenosine Monophosphate (AMP)IBA 12/2021
1	Metformin (Glucophage)FDA LinkGeneric 12/2021
1	AICA ribonucleotide (ZMP)IBA 12/2021
1	purineIBA 10/2021
1	Double-Stranded RNA (RNA, Double Stranded)IBA 10/2021
1	Long Noncoding RNAIBA 10/2021
1	DNA (Deoxyribonucleic Acid)IBA 10/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	AntagomirsIBA 01/2021
1	Amino Acid Transport System X-AG (Glutamate Transporter)IBA 01/2021
1	Calcitriol Receptors (Calcitriol Receptor)IBA 02/2020
1	Peptides (Polypeptides)IBA 02/2020
1	myelin oligodendrocyte glycoprotein (35-55)IBA 02/2020
1	TRPV1 receptorIBA 01/2020
1	LigandsIBA 01/2020

Therapy/Procedure

10	Spinal Injections 12/2021 - 12/2012
8	Therapeutics 01/2021 - 01/2002
5	Intraperitoneal Injections 01/2020 - 05/2013
2	Analgesia 12/2021 - 02/2013
2	Injections 01/2016 - 01/2002
2	Electroacupuncture 02/2013 - 12/2012
1	Transcranial Direct Current Stimulation 01/2021